Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Synthego Corporation Inter Partes Review
Case Number:
Case Type:
IPR
Status:
Final Written Decision - Appealed
Petitioner:
Synthego Corporation
-
May 17, 2023
Synthego Gets PTAB To Ax 2 Agilent CRISPR Patents
The Patent Trial and Appeal Board found Wednesday that two Agilent Technologies Inc. patents on the gene-editing tool CRISPR were invalid, the latest dustup in a legal fight brought by Synthego Corp. over the breakthrough technology.
-
June 01, 2022
Synthego Gets PTAB To Review 2 Full CRISPR Patents
The Patent Trial and Appeal Board has agreed to review whether two Agilent Technologies Inc. patents related to the breakthrough gene-editing technology CRISPR should be invalidated.